John D Beard1, Aaron Erdely2, Matthew M Dahm3, Marie A de Perio3, M Eileen Birch4, Douglas E Evans4, Joseph E Fernback4, Tracy Eye2, Vamsi Kodali2, Robert R Mercer2, Stephen J Bertke3, Mary K Schubauer-Berigan3. 1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health, Cincinnati, OH, USA. Electronic address: john_beard@byu.edu. 2. Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA. 3. Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health, Cincinnati, OH, USA. 4. Division of Applied Research and Technology, National Institute for Occupational Safety and Health, Cincinnati, OH, USA.
Abstract
BACKGROUND: Carbon nanotubes and nanofibers (CNT/F) are increasingly used for diverse applications. Although animal studies suggest CNT/F exposure may cause deleterious health effects, human epidemiological studies have typically been small, confined to single workplaces, and limited in exposure assessment. OBJECTIVES: We conducted an industrywide cross-sectional epidemiological study of 108 workers from 12 U.S. sites to evaluate associations between occupational CNT/F exposure and sputum and blood biomarkers of early effect. METHODS: We assessed CNT/F exposure via personal breathing zone, filter-based air sampling to measure background-corrected elemental carbon (EC) (a CNT/F marker) mass and microscopy-based CNT/F structure count concentrations. We measured 36 sputum and 37 blood biomarkers. We used factor analyses with varimax rotation to derive factors among sputum and blood biomarkers separately. We used linear, Tobit, and unconditional logistic regression models to adjust for potential confounders and evaluate associations between CNT/F exposure and individual biomarkers and derived factors. RESULTS: We derived three sputum and nine blood biomarker factors that explained 78% and 67%, respectively, of the variation. After adjusting for potential confounders, inhalable EC and total inhalable CNT/F structures were associated with the most sputum and blood biomarkers, respectively. Biomarkers associated with at least three CNT/F metrics were 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2), interleukin-18, glutathione peroxidase (GPx), myeloperoxidase, and superoxide dismutase (SOD) in sputum and MMP-2, matrix metalloproteinase-9, metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1, 8-hydroxy-2'-deoxyguanosine, GPx, SOD, endothelin-1, fibrinogen, intercellular adhesion molecule 1, vascular cell adhesion protein 1, and von Willebrand factor in blood, although directions of associations were not always as expected. CONCLUSIONS: Inhalable rather than respirable CNT/F was more consistently associated with fibrosis, inflammation, oxidative stress, and cardiovascular biomarkers. Published by Elsevier Ltd.
BACKGROUND:Carbon nanotubes and nanofibers (CNT/F) are increasingly used for diverse applications. Although animal studies suggest CNT/F exposure may cause deleterious health effects, human epidemiological studies have typically been small, confined to single workplaces, and limited in exposure assessment. OBJECTIVES: We conducted an industrywide cross-sectional epidemiological study of 108 workers from 12 U.S. sites to evaluate associations between occupational CNT/F exposure and sputum and blood biomarkers of early effect. METHODS: We assessed CNT/F exposure via personal breathing zone, filter-based air sampling to measure background-corrected elemental carbon (EC) (a CNT/F marker) mass and microscopy-based CNT/F structure count concentrations. We measured 36 sputum and 37 blood biomarkers. We used factor analyses with varimax rotation to derive factors among sputum and blood biomarkers separately. We used linear, Tobit, and unconditional logistic regression models to adjust for potential confounders and evaluate associations between CNT/F exposure and individual biomarkers and derived factors. RESULTS: We derived three sputum and nine blood biomarker factors that explained 78% and 67%, respectively, of the variation. After adjusting for potential confounders, inhalable EC and total inhalable CNT/F structures were associated with the most sputum and blood biomarkers, respectively. Biomarkers associated with at least three CNT/F metrics were 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2), interleukin-18, glutathione peroxidase (GPx), myeloperoxidase, and superoxide dismutase (SOD) in sputum and MMP-2, matrix metalloproteinase-9, metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1, 8-hydroxy-2'-deoxyguanosine, GPx, SOD, endothelin-1, fibrinogen, intercellular adhesion molecule 1, vascular cell adhesion protein 1, and von Willebrand factor in blood, although directions of associations were not always as expected. CONCLUSIONS: Inhalable rather than respirable CNT/F was more consistently associated with fibrosis, inflammation, oxidative stress, and cardiovascular biomarkers. Published by Elsevier Ltd.
Authors: Chanelle J Howe; Stephen R Cole; Daniel J Westreich; Sander Greenland; Sonia Napravnik; Joseph J Eron Journal: Epidemiology Date: 2011-11 Impact factor: 4.822
Authors: Irina Guseva Canu; Thomas F Bateson; Veronique Bouvard; Maximilien Debia; Chantal Dion; Kai Savolainen; Il-Je Yu Journal: Int J Hyg Environ Health Date: 2015-12-23 Impact factor: 5.840
Authors: Mario J Aragon; Lauren Topper; Christina R Tyler; Bethany Sanchez; Katherine Zychowski; Tamara Young; Guy Herbert; Pamela Hall; Aaron Erdely; Tracy Eye; Lindsey Bishop; Samantha A Saunders; Pretal P Muldoon; Andrew K Ottens; Matthew J Campen Journal: Proc Natl Acad Sci U S A Date: 2017-02-21 Impact factor: 11.205
Authors: Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Timur O Khailullin; M Eileen Birch; Liliya M Fatkhutdinova Journal: PLoS One Date: 2016-03-01 Impact factor: 3.240
Authors: Aaron Erdely; Matthew Dahm; Bean T Chen; Patti C Zeidler-Erdely; Joseph E Fernback; M Eileen Birch; Douglas E Evans; Michael L Kashon; James A Deddens; Tracy Hulderman; Suzan A Bilgesu; Lori Battelli; Diane Schwegler-Berry; Howard D Leonard; Walter McKinney; David G Frazer; James M Antonini; Dale W Porter; Vincent Castranova; Mary K Schubauer-Berigan Journal: Part Fibre Toxicol Date: 2013-10-21 Impact factor: 9.400
Authors: Timur O Khaliullin; Naveena Yanamala; Mackenzie S Newman; Elena R Kisin; Liliya M Fatkhutdinova; Anna A Shvedova Journal: Toxicol Appl Pharmacol Date: 2020-01-22 Impact factor: 4.219
Authors: Mary K Schubauer-Berigan; Matthew M Dahm; Christine A Toennis; Deborah L Sammons; Tracy Eye; Vamsi Kodali; Patti C Zeidler-Erdely; Aaron Erdely Journal: Nanotoxicology Date: 2020-02-07 Impact factor: 5.913
Authors: Hao Chen; Sara T Humes; Sarah E Robinson; Julia C Loeb; Indu V Sabaraya; Navid B Saleh; Ram B Khattri; Matthew E Merritt; Christopher J Martyniuk; John A Lednicky; Tara Sabo-Attwood Journal: Nanotoxicology Date: 2019-09-27 Impact factor: 5.913
Authors: Steven M Thygerson; John D Beard; Marion J House; Rilee L Smith; Hunter C Burbidge; Kathryn N Andrus; Frank X Weber; Ryan Chartier; James D Johnston Journal: Int J Environ Res Public Health Date: 2019-10-25 Impact factor: 3.390
Authors: Mary K Schubauer-Berigan; Matthew M Dahm; Aaron Erdely; John D Beard; M Eileen Birch; Douglas E Evans; Joseph E Fernback; Robert R Mercer; Stephen J Bertke; Tracy Eye; Marie A de Perio Journal: Part Fibre Toxicol Date: 2018-05-16 Impact factor: 9.400